Health
FDA authorizes marketing of new device designed to remove dead pancreatic tissue – FDA.gov
): FDA granted de novo for the EndoRotor System to resection (cut out) and remove necrotic (dead) tissue for patients with walled-off pancreatic necrosis.
For Immediate Release:
December 23, 2020
Today, the U.S. Food and Drug Administration authorized marketing of the EndoRotor System to resect (cut out) and remove necrotic (dead) tissue for patients with walled-off pancreatic necrosis (WOPN), a potentially deadly condition which can occur several weeks after an episode of severe acute pancreatitis, often requiring tissue removal.
This device has shown its potential to provide a minimally invasive way to remove harmful necrotic pancreatic tissue…
-
Noosa News17 hours agoHow Lily Steele-Park took her rapist to court and won
-
Business21 hours agoFord CEO makes stunning prediction about artificial intelligence
-
Business19 hours ago5 things to watch on the ASX 200 on Tuesday 8 July 2025
-
General22 hours agoRush to buy homes before rate cuts send prices soaring